The Link Between Human Cytomegalovirus Gene Expression and Glutamate Level in Migraine;Relation to Vitamin D Deficiency - Trial NCT06304948
Access comprehensive clinical trial information for NCT06304948 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Migraine. Target enrollment is 72 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Assiut University
Timeline & Enrollment
N/A
May 01, 2024
Feb 01, 2025
Primary Outcome
The Link between human cytomegalovirus gene expression and glutamate levels in Migraine :relationship to the Vit D Deficiency
Summary
1. To correlate serum 25(OH)-vitamin D level with duration, frequency, and severity of
 migraine headache attacks
 
 2. To evaluate the relationship between the serum level of vitamin D and other indices in
 patients with migraine.
 
 3. To correlate the serum level of glutamate with gene expression of in migraine
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06304948
Non-Device Trial